Fig. 1 · Structure
Documents & Downloads
UCM710
eCB Hydrolysis Inhibitor
UCM710 is an endocannabinoid hydrolysis inhibitor that enhances the levels of N-arachidonoyl ethanolamine and 2-arachidonoylglycerol in neuronal cells. It specifically inhibits fatty acid amide hydrolase and α/β-hydrolase domain 6, while having no effect on monoacylglycerol lipase. UCM710 is utilized in research focused on endocannabinoid signaling pathways and their implications in neurobiology.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| Actions | Inhibitor |
| CAS Number | 213738-77-3 |
| Applications | eCB Hydrolysis Inhibitor |
| Formula | C19H34O3 |
| Molecular Weight | 310.47 |
| SMILES | CCCCCC/C=C\CCCCCCCC(OCC1OC1)=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.